M. S. De Propris

766 total citations
16 papers, 432 citations indexed

About

M. S. De Propris is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, M. S. De Propris has authored 16 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 7 papers in Pathology and Forensic Medicine and 7 papers in Hematology. Recurrent topics in M. S. De Propris's work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). M. S. De Propris is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). M. S. De Propris collaborates with scholars based in Italy and United States. M. S. De Propris's co-authors include Anna Guarini, Robin Foà, R. Foà, Sara Raponi, Sabina Chiaretti, Francesca Romana Mauro, Irene Della Starza, Maria Laura Milani, Ilaria Del Giudice and Nadia Peragine and has published in prestigious journals such as Blood, Transplantation and British Journal of Haematology.

In The Last Decade

M. S. De Propris

16 papers receiving 429 citations

Peers

M. S. De Propris

HEMAT

GENET

IMMUN

PFM

ONCOL

Irene Della Starza Italy

Patrick Villarèse France

Santiago Gardella Spain

Ángel Ramírez Páyer Spain

M. P. A. Lyttelton United Kingdom

Nils Winkelmann Germany

D Leboeuf France

H. T. Kim United States

Luk Cox Belgium

Sara Marietti Italy

Irene Della Starza Italy

M. S. De Propris

178 ×0.9

HEMAT

203 ×1.3

GENET

101 ×0.7

IMMUN

233 ×1.8

PFM

144 ×1.1

ONCOL

Citations per year, relative to M. S. De Propris M. S. De Propris (= 1×) peers Irene Della Starza

Countries citing papers authored by M. S. De Propris

Since Specialization

Citations

This map shows the geographic impact of M. S. De Propris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. S. De Propris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. S. De Propris more than expected).

Fields of papers citing papers by M. S. De Propris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. S. De Propris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. S. De Propris. The network helps show where M. S. De Propris may publish in the future.

Co-authorship network of co-authors of M. S. De Propris

This figure shows the co-authorship network connecting the top 25 collaborators of M. S. De Propris. A scholar is included among the top collaborators of M. S. De Propris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. S. De Propris. M. S. De Propris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Annechini, Giorgia, et al.. (2023). Early clearance of hairy cell leukaemia in the bone marrow after first‐line treatment with cladribine predicts a favourable outcome. British Journal of Haematology. 204(4). 1288–1292. 1 indexed citations

Chiaretti, Sabina, Renato Bassan, L Elia, et al.. (2022). P353: FORTY MONTHS UPDATE OF THE GIMEMA LAL2116 (D-ALBA) PROTOCOL AND ANCILLARY LAL2217 STUDY FOR NEWLY DIAGNOSED ADULT PH+ ALL. HemaSphere. 6. 253–254. 20 indexed citations

Starza, Irene Della, Sabina Chiaretti, M. S. De Propris, et al.. (2019). Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances. Frontiers in Oncology. 9. 726–726. 80 indexed citations

Mauro, Francesca Romana, Angelo Michele Carella, Stefano Molica, et al.. (2016). Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I–II GIMEMA trial. Leukemia & lymphoma. 58(7). 1640–1647. 9 indexed citations

Torelli, G, Nadia Peragine, Sara Raponi, et al.. (2014). Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells. Haematologica. 99(7). 1248–1254. 50 indexed citations

Raponi, Sara, Irene Della Starza, M. S. De Propris, et al.. (2014). Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ‐PCR. British Journal of Haematology. 166(3). 360–368. 23 indexed citations

Marinelli, M, Nadia Peragine, Valeria Di Maio, et al.. (2012). Identification of molecular and functional patterns of p53 alterations in chronic lymphocytic leukemia patients in different phases of the disease. Haematologica. 98(3). 371–375. 17 indexed citations

Guarini, Anna, M Marinelli, Simona Tavolaro, et al.. (2011). ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression. Haematologica. 97(1). 47–55. 70 indexed citations

Torelli, G, Barbarella Lucarelli, Anna Paola Iori, et al.. (2011). The immune reconstitution after an allogeneic stem cell transplant correlates with the risk of graft-versus-host disease and cytomegalovirus infection. Leukemia Research. 35(8). 1124–1126. 6 indexed citations

10.

Propris, M. S. De, Sara Raponi, Daniela Diverio, et al.. (2011). High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation. Haematologica. 96(10). 1548–1551. 69 indexed citations

11.

Giudice, Ilaria Del, Francesca Romana Mauro, M. S. De Propris, et al.. (2010). White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia. Haematologica. 96(4). 626–630. 19 indexed citations

12.

Giudice, Ilaria Del, Stefano Pileri, Maura Rossi, et al.. (2009). Histopathological and molecular features of persistent polyclonal B‐cell lymphocytosis (PPBL) with progressive splenomegaly. British Journal of Haematology. 144(5). 726–731. 19 indexed citations

13.

Raponi, Sara, M. S. De Propris, L Elia, et al.. (2009). An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia. Haematologica. 94(12). 1767–1770. 12 indexed citations

14.

Iori, Anna Paola, G Torelli, M. S. De Propris, et al.. (2008). B-Cell Concentration in the Apheretic Product Predicts Acute Graft-Versus-Host Disease and Treatment-Related Mortality of Allogeneic Peripheral Blood Stem Cell Transplantation. Transplantation. 85(3). 386–390. 33 indexed citations

15.

Tavolaro, Simona, Roberta Maggio, Nadia Peragine, et al.. (2007). IgVH Germline and Mutated Chronic Lymphocytic Leukemia (CLL) Cases Exert a Diverse Responsiveness upon BCR Ligation.. Blood. 110(11). 1133–1133. 2 indexed citations

16.

Mauro, Francesca Romana, M. S. De Propris, Giuseppe Gentile, et al.. (2006). Fludarabine, Ara-C, Novantrone and Dexamethasone Plus Campath-1H for the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL) and Adverse Clinical and Biologic Prognostic Features.. Blood. 108(11). 2830–2830. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact